In this Denatured episode, Jennifer C. Smith-Parker speaks to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We’ll discuss patient ...
The U.S. Congress greenlit a historic $315 million in federal ALS research funding for 2026 amid Rare Disease Month, spotlighting biotech progress like VectorY Therapeutics’ first patient dosing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results